Factors Associated with Poor Glycemic Control among Type 2 Diabetics Followed at Yopougon University Hospital

Abstract

Diabetes mellitus is recognized worldwide as a public health problem due to its ever-increasing prevalence and its complications. This study aims to identify the factors associated with poor glycemic control in people with type 2 diabetes in order to improve their management. This was a cross-sectional analytical study of patients with type 2 diabetes followed at the Yopougon University Hospital from January 2020 to March 31, 2021. Poor glycemic control was defined as an HbA1c level of ≥7%. A multivariate logistic regression analysis was performed to identify independently associated factors. During our study, we enrolled a total of 300 patients, of whom 196 (65.3%) had poor glycemic control. In the multivariate analysis, the factors associated with poor glycemic control were: nonadherence to treatment (ORa = 4.12; 95% CI [2.34 - 7.26]; p < 0.001), failure to follow the diet (ORa = 3.58; 95% CI [2.01 - 6.37]; p < 0.001), use of traditional medicine (ORa = 3.21; p = 0.001), and duration of diabetes ≥ 5 years (ORa = 2.87; p = 0.002), obesity (ORa = 2.43; p = 0.004), lack of health insurance (ORa = 2.18; p = 0.012), and low educational attainment (ORa = 1.96; p = 0.031). Poor glycemic control is common among people with diabetes receiving care at the Yopougon health center. To improve it, it will be necessary to intensify therapeutic education, step up treatment, and improve health coverage.

Share and Cite:

Beroh, L. , Nodje-Assal, N. , Affadine, H. , Néni, D. , Marschall, M. , Assita, Y. and Fetè, A. (2026) Factors Associated with Poor Glycemic Control among Type 2 Diabetics Followed at Yopougon University Hospital. Journal of Diabetes Mellitus, 16, 113-121. doi: 10.4236/jdm.2026.164009.

1. Introduction

Diabetes mellitus is a chronic disease recognized worldwide as a devastating epidemic [1]. The International Diabetes Federation (IDF) estimated that in 2019, 463 million people worldwide were living with diabetes, and that this figure will reach 700 million by 2045 if nothing is done [2]. Type 2 diabetes accounts for the large majority of cases, at 90% [3]. Its progression is driven by changing economic conditions and lifestyles associated with urbanization, together with population aging [4] [5]. This increase is of great concern because of its cardiovascular complications, which are a major source of morbidity and mortality: disability, functional impairment, reduced quality of life, and heavy healthcare costs.

Africa is not spared from this trend. The IDF estimated that 19 million people in the African population were living with diabetes in 2019 [6]. One of the challenges facing healthcare providers is to ensure rigorous management that takes into account all cardiovascular risk factors, in order to prevent complications and improve these patients’ quality of life.

It is well established that improved glycemic control is associated with a reduction in microvascular and macrovascular complications [7]. Good glycemic control is defined as a glycated hemoglobin (HbA1c) level of 7% or lower [8]. However, this glycemic target remains difficult to achieve in most cases. Indeed, the prevalence of poor glycemic control among type 2 diabetics in sub-Saharan Africa varies widely: 81% in Burundi [9], 68% in Cameroon, and 84% in Guinea [10].

In Côte d’Ivoire, there are few data on the prevalence of poor glycemic control among type 2 diabetics, and even fewer on its associated factors. Identifying these factors could help improve the management of diabetic patients and prevent potential complications. This is the purpose of our study.

2. Materials and Methods

2.1. Study Design and Setting

This was an analytical, cross-sectional study conducted from January 2020 to March 30, 2021, in the Endocrinology-Diabetology Department of Yopougon University Hospital in Abidjan, specifically within its outpatient consultation unit.

2.2. Study Population and Inclusion Criteria

The study population consisted of all type 2 diabetic patients followed at Yopougon University Hospital during the study period.

  • Inclusion criteria:

  • Patients with a diagnosis of type 2 diabetes established according to WHO criteria, followed at Yopougon University Hospital for at least 6 months.

  • Type 2 diabetic patients followed at Yopougon University Hospital who had undergone the HbA1c test at least twice.

  • Non-inclusion criteria:

  • Patients with a type of diabetes other than type 2;

  • Patients with confirmed cardiovascular disease or a comorbidity for whom the 7% target is difficult to achieve because of the risk of hypoglycemia;

  • Type 2 diabetic patients who became pregnant during follow-up.

2.3. Variables Studied

Poor glycemic control was defined as an HbA1c level ≥ 7%, in accordance with the recommendations of the American Diabetes Association (ADA) and the African Society for Diabetology and Endocrinology (SFADE).

  • The variables studied included:

  • Sociodemographic factors (age, sex, education level, occupation);

  • Clinical factors (diabetes duration, body mass index, treatment type, comorbidity).

2.4. Data Collection

We initially identified the records of all patients who had consulted Yopougon University Hospital for type 2 diabetes. We then listed the patients with poor glycemic control who met our inclusion criteria and administered pre-established questionnaires to them.

2.5. Data Analysis

The collected data were entered and analyzed using EPI-INFO version 7 software. Tables, graphs, and figures were produced using Microsoft Office 2010 Excel and Word. Univariate analysis was performed using the chi-square independence test. The difference was considered statistically significant when p < 0.05.

3. Results

During the study period, 568 patients consulted Yopougon University Hospital, of whom 300 met the study criteria (52.7%). The 268 exclusions were related to incomplete records, pregnancy, and type 1 diabetes. The study population comprised 186 women (62.0%) and 114 men (38.0%), giving a sex ratio of 1.63. The mean age was 52.4 ± 11.8 years (See Table 1).

Table 1. Distribution of poor glycemic control according to sociodemographic characteristics (n = 300).

Variable

n (%)

HbA1c ≥ 7% n (%)

Female sex

186 (62.0%)

127 (68.3%)

Male sex

114 (38.0%)

69 (60.5%)

Mean age ± SD (years)

52.4 ± 11.8

-

Age < 40 years

54 (18.0%)

40 (74.1%)

Age 40 - 60 years

162 (54.0%)

108 (66.7%)

Age > 60 years

84 (28.0%)

48 (57.1%)

No education/primary school

132 (44.0%)

98 (74.2%)

Secondary/higher education

168 (56.0%)

98 (58.3%)

Insured patients

126 (42.0%)

69 (54.8%)

Uninsured patients

174 (58.0%)

127 (73.0%)

The overall prevalence of poor glycemic control (HbA1c ≥ 7%) was 65.3% (196/300); the mean HbA1c value in the population was 8.4%, ranging from 5.2% to 14.6% (See Tables 1-3).

Table 2. Distribution of poor glycemic control according to clinical factors (n = 300).

Clinical variable

n (%)

HbA1c ≥ 7% n (%)

Diabetes duration < 5 years

102 (34.0%)

57 (55.9%)

Diabetes duration ≥ 5 years

198 (66.0%)

139 (70.2%)

Obesity (BMI ≥ 30 kg/m2)

138 (46.0%)

104 (75.4%)

Associated hypertension

168 (56.0%)

117 (69.6%)

Insulin therapy

84 (28.0%)

63 (75.0%)

Dual oral therapy

126 (42.0%)

82 (65.1%)

Oral monotherapy

90 (30.0%)

51 (56.7%)

Table 3. Distribution of poor glycemic control according to behavioral factors (n = 300).

Behavioral factor

n (%)

HbA1c ≥ 7% n (%)

Therapeutic non-adherence

186 (62.0%)

148 (79.6%)

Dietary recommendations not followed

204 (68.0%)

156 (76.5%)

Sedentary lifestyle (<150 min/week)

222 (74.0%)

164 (73.9%)

Traditional self-medication

114 (38.0%)

91 (79.8%)

Irregular follow-up (<4 visits/year)

168 (56.0%)

126 (75.0%)

Clinical Factors Associated with Poor Glycemic Control

In the study population, 198 patients (66.0%) had been living with diabetes for more than 5 years (See Table 2). Obesity (BMI ≥ 30 kg/m2) affected 128 patients (46.0%); 168 patients (58.0%) also had arterial hypertension; and the majority of patients were on dual oral therapy, 126 (42.0%).

4. Discussion

4.1. Sociodemographic Factors

During our study period, 568 diabetic patients consulted at Yopougon University Hospital, of whom we included 300. Of these 300 patients, 196 had poor glycemic control (HbA1c ≥ 7%), giving a prevalence of 65.3%. This prevalence is comparable to that reported by Amoah et al. in Ghana (63.2%) [11] and by Lokrou et al. in Côte d’Ivoire (61%) [12]. These figures highlight the need to optimize diabetes treatment in developing countries in order to minimize its complications. Our data contrast with those of Cai in China (31.5%) [13].

The mean HbA1c value was 8.4%, a concerning figure given the associated complications. Indeed, each 1% increase in HbA1c is associated with an increased risk of complications: a 37% increase in the risk of macrovascular complications and a 14% increase in the risk of myocardial infarction, according to UKPDS data [14].

The mean age was 52.4 ± 11.8 years, with the 40 - 60 year age group predominating. The same finding was reported by Barankanira in Burundi [9]. The high proportion of relatively young patients in our study is concerning and raises questions about the challenges to be addressed in preventing cardiovascular complications and the risk of premature death.

Unlike the findings of Al-Nuaim et al. in Saudi Arabia [15] and Traoré et al. in Burkina Faso [16], who identified sex as a factor associated with poor glycemic control, sex was not a risk factor for poor glycemic control in our study. The same finding was reported by Ben Abdelaziz et al. in Tunis [17].

Financial dependence and lack of health insurance coverage (aOR = 2.18) negatively affect glycemic balance (Table 4). These results confirm those reported in the literature, which show that low socioeconomic status affects access to healthcare services and quality of care [18]-[20].

Table 4. Independent factors associated with poor glycemic control—Multivariate analysis (n = 300).

Associated factor

Adjusted OR

95% CI

p-value

Therapeutic non-adherence

4.12

[2.34 - 7.26]

<0.001

Non-adherence to dietary recommendations

3.58

[2.01 - 6.37]

<0.001

Traditional self-medication

3.21

[1.72 - 5.98]

0.001

Diabetes duration ≥ 5 years

2.87

[1.54 - 5.35]

0.002

Obesity (BMI ≥ 30 kg/m2)

2.43

[1.38 - 4.28]

0.004

Uninsured patients

2.18

[1.22 - 3.89]

0.012

Low education level

1.96

[1.10 - 3.50]

0.031

Irregular follow-up (<4 visits/year)

1.84

[1.04 - 3.25]

0.043

Regarding educational status, a low education level (aOR = 1.96) was associated with poor glycemic control in our study. Our data corroborate many other studies that have found an association between low education level and poor glycemic control [21] [22]. This result may be explained by the difficulty these patients have in understanding therapeutic education, leading them to resort more often to traditional treatment for managing their diabetes.

4.2. Diabetes-Related Data

In the literature, opinions on the relationship between diabetes duration and glycemic control are divided. Some authors found that diabetes duration was not a risk factor for poor glycemic control [23]. Others reported that a duration greater than 10 years was associated with poor glycemic control [24], while still others found the opposite [25] [26]. For Valle et al., newly diagnosed patients (<3 years) had good glycemic control [27]. In our study, a diabetes duration of more than 5 years (aOR = 2.87) was associated with poor control, with a statistically significant difference. This difference may be explained by the progressive deterioration of pancreatic beta-cell function in the islets of Langerhans over time, which makes glycemic balance increasingly difficult to achieve.

Regarding cardiovascular risk factors, obesity (BMI ≥ 30 kg/m2) was a risk factor for poor glycemic control in our study (aOR = 2.43). This finding was also reported by Bruno G. and Blaum CS et al. [28] [29]. Indeed, obesity causes insulin resistance, and the high prevalence of obese patients in our study worsened the risk of poor glycemic control. Factors such as arterial hypertension and dyslipidemia were not risk factors for poor glycemic control in our study.

4.3. Behavioral Factors

Among the behavioral factors associated with poor glycemic control, we identified therapeutic non-adherence, non-adherence to dietary recommendations, and reliance on traditional therapy as strongly associated factors.

Non-adherence to treatment is an obstacle to good glycemic balance (aOR = 4.12). This result is consistent with the meta-analysis by Krass et al. of 28 studies, which concluded that non-adherence multiplies the risk of poor glycemic control by 3 to 5 times [30]. In our study, the reasons cited by patients for non-adherence to treatment included financial difficulties in purchasing medications and attending consultations, mistaken beliefs about chronic illness, and reliance on traditional therapy.

The second behavioral factor associated with poor glycemic control was non-adherence to dietary recommendations (aOR = 3.58). Dietary recommendations are difficult to follow.

This observation highlights the need to adapt nutritional advice to local dietary habits, as recommended by several authors [31] [32].

The third factor identified in our study was reliance on traditional therapy (aOR = 3.21). Numerous Sahelian and West African studies have reported prevalences ranging from 30% to 55%. This phenomenon is often responsible for interruptions in conventional treatment [33].

5. Conclusion

Poor glycemic control is frequently encountered among diabetics followed at Yopougon University Hospital, mainly driven by therapeutic non-adherence, non-adherence to dietary recommendations, and reliance on traditional medicine, together with a long diabetes duration, obesity, lack of health insurance coverage, and low education level. Improving glycemic control in this population will require intensifying therapeutic education, intensifying insulin therapy where indicated, and extending health insurance coverage to a greater number of patients.

Author Contributions

Author 1 initiated the project; co-authors 2 and 3 contributed to the analysis and writing. The other co-authors contributed to proofreading, guiding the writing process, and editing the manuscript.

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

References

[1] World Health Organization (2017) Global Report on Diabetes. World Health Organization.
https://www.who.int/publications/i/item/9789241565257
[2] International Diabetes Federation (2019) IDF Diabetes Atlas. 9th Edition.
https://diabetesatlas.org/resources/previous-editions/
[3] Thomsen, S., Kristensen, G.D.W., Jensen, N.W.H. and Agergaard, S. (2021) Maintaining Changes in Physical Activity among Type 2 Diabetics—A Systematic Review of Rehabilitation Interventions. Scandinavian Journal of Medicine & Science in Sports, 31, 1582-1591.[CrossRef] [PubMed]
[4] Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (2014) Cardiovascular Disease, Chronic Kidney Disease, and Diabetes Mortality Burden of Cardiometabolic Risk Factors from 1980 to 2010: A Comparative Risk Assessment. The Lancet Diabetes & Endocrinology, 2, 634-647.
[5] Wingard, D.L. and Barrett-Connor, E. (1995) Heart Disease and Diabetes. In: Harris, M.I., Cowie, C.C., Stern, M.P., Boyko, E.J., Reiber, G.E., Bennett, P.H., Eds., Diabetes in America, 2nd Edition, National Institutes of Health, 429-448.
https://www.niddk.nih.gov/-/media/Files/Strategic-Plans/Diabetes-in-America-2nd-Edition/chapter19.pdf
[6] Schlienger, J.L. (2019) Modifications thérapeutiques du mode de vie et prévention cardiovasculaire chez les sujets diabétiques de type 2. Médecine des Maladies Métaboliques, 13, 27-35.[CrossRef]
[7] American Diabetes Association (2012) Standards of Medical Care in Diabetes-2012. Diabetes Care, 35, S11-S63.
[8] Cheng, A.Y.Y. and Lau, D.C.W. (2013) The Canadian Diabetes Association 2013 Clinical Practice Guidelines—Raising the Bar and Setting Higher Standards! Canadian Journal of Diabetes, 37, 137-138.[CrossRef] [PubMed]
[9] Barankanira, E., Iradukunda, A. and Ntakaburimvo, N. (2019) Determinants of Poor Glycemic Control in Burundi. Science, 15, 74-87.
https://ens.edu.bi/wp-content/uploads/2024/08/Facteurs-determinants-du-mauvais-controle-glycemique-au-Burundi.pdf
[10] Lokrou, A. (2008) Practical Guide to the Management of Diabetic Patients., 1st Edition, EDUCI, 58-143.
[11] Amoah, A.G.B., Owusu, S.K. and Adjei, S. (2002) Diabetes in Ghana: A Community Based Prevalence Study in Greater Accra. Diabetes Research and Clinical Practice, 56, 197-205.[CrossRef] [PubMed]
[12] Lokrou, A., Ouédraogo, A. and Tiahou, G. (2019) Prevalence and Control of Type 2 Diabetes in Côte d’Ivoire: A Multicenter Study. Médecine d’Afrique Noire, 66, 142-149.
[13] Cai, X.L., Hu, D.Y., Pan, C.Y., Li, G.W., Lu, J.M., Ji, Q.H., et al. (2019) Evaluation of Effectiveness of Treatment Paradigm for Newly Diagnosed Type 2 Diabetes Patients in Chin: A Nationwide Prospective Cohort Study. Journal of Diabetes Investigation, 11, 151-161.[CrossRef] [PubMed]
[14] Stratton, I.M., Adler, A.I., Neil, H.A., Matthews, D.R., Manley, S.E., Cull, C.A., et al. (2000) Association of Glycaemia with Macrovascular and Microvascular Complications of Type 2 Diabetes (UKPDS 35): Prospective Observational Study. BMJ, 321, 405-412.[CrossRef] [PubMed]
[15] Al-Nuaim, A.R., Mirdad, S., Al-Rubeaan, K., Al-Mazrou, Y., Al-Attas, O. and Al-Daghari, N. (1998) Pattern and Factors Associated with Glycemic Control of Saudi Diabetic Patients. Annals of Saudi Medicine, 18, 109-112.[CrossRef] [PubMed]
[16] Traoré, S., Guira, O., Zoungrana, L., Sagna, Y., Bognounou, R., B. Paré, C., et al. (2021) Factors Associated with Prolonged Poor Glycemic Control in Type 2 Diabetes Mellitus (T2DM) Patients Followed in the Department of Internal Medicine at the Yalgado Ouedraogo Teaching Hospital, Ouagadougou (Burkina Faso). Open Journal of Internal Medicine, 11, 1-26. [Google Scholar] [CrossRef]
[17] American Diabetes Association (2019) 3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2020. Diabetes Care, 43, S32-S36.[CrossRef] [PubMed]
[18] Herman, W.H. and Cohen, R.M. (2012) Racial and Ethnic Differences in the Relationship between Hba1c and Blood Glucose: Implications for the Diagnosis of Diabetes. The Journal of Clinical Endocrinology & Metabolism, 97, 1067-1072.[CrossRef] [PubMed]
[19] Demoz, G.T., Gebremariam, A., Yifter, H., Alebachew, M., Niriayo, Y.L., Gebreslassie, G., et al. (2019) Predictors of Poor Glycemic Control among Patients with Type 2 Diabetes on Follow-Up Care at a Tertiary Healthcare Setting in Ethiopia. BMC Research Notes, 12, Article No. 207.[CrossRef] [PubMed]
[20] Boutayeb, W., Lamlili, M., Ben El Mostafa, S. and Boutayeb, A. (2015) Inégalités socioéconomiques au Maroc : un frein au développement humain. Annales des Sciences de la Santé, 1, 3-10.
https://revues.imist.ma/index.php/A2S/article/view/3315
[21] Ben El Mostafa, S., Boutayeb, W., Zitouni, N. and Maamri, A. (2019) Revue des inégalités au Maroc avec illustrations multi-domaines. Annales des Sciences de la Santé, 22, 1-14.
https://revues.imist.ma/index.php/A2S
[22] Afroz, A., Ali, L., Karim, M.N., Alramadan, M.J., Alam, K., Magliano, D.J., et al. (2019) Glycaemic Control for People with Type 2 Diabetes Mellitus in Bangladesh—An Urgent Need for Optimization of Management Plan. Scientific Reports, 9, Article No. 10248.[CrossRef] [PubMed]
[23] Selim, S., Pathan, F., Saifuddin, M., Latif, Z.A. and Karim, N. (2016) The Challenge of Proper Glycaemic Control among Patients with Type 2 Diabetes in Bangladesh. Sri Lanka Journal of Diabetes Endocrinology and Metabolism, 6, Article 16.[CrossRef]
[24] Khunti, K., Chen, H., Cid‐Ruzafa, J., Fenici, P., Gomes, M.B., Hammar, N., et al. (2019) Glycaemic Control in Patients with Type 2 Diabetes Initiating Second‐Line Therapy: Results from the Global DISCOVER Study Programme. Diabetes, Obesity and Metabolism, 22, 66-78.[CrossRef] [PubMed]
[25] Sanal, T., Nair, N. and Adhikari, P. (2011) Factors Associated with Poor Control of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Journal of Diabetology, 2, Article 4.[CrossRef]
[26] Mendes, A.B.V., Fittipaldi, J.A.S., Neves, R.C.S., Chacra, A.R. and Moreira, E.D. (2010) Prevalence and Correlates of Inadequate Glycaemic Control: Results from a Nationwide Survey in 6,671 Adults with Diabetes in Brazil. Acta Diabetologica, 47, 137-145.[CrossRef] [PubMed]
[27] Valle, T., Koivisto, V.A., Reunanen, A., Kangas, T. and Rissanen, A. (1999) Glycemic Control in Patients with Diabetes in Finland. Diabetes Care, 22, 575-579.[CrossRef] [PubMed]
[28] Bruno, G., Cavallo-Perin, P., Bargero, G., Borra, M., D’Errico, N. and Pagano, G. (1998) Glycaemic Control and Cardiovascular Risk Factors in Type 2 Diabetes: A Population-Based Study. Diabetic Medicine, 15, 304-307.[CrossRef] [PubMed]
[29] Blaum, C.S., Velez, L., Hiss, R.G. and Halter, J.B. (1997) Characteristics Related to Poor Glycemic Control in NIDDM Patients in Community Practice. Diabetes Care, 20, 7-11.[CrossRef] [PubMed]
[30] Krass, I., Schieback, P. and Dhippayom, T. (2015) Adherence to Diabetes Medication: A Systematic Review. Diabetic Medicine, 32, 725-737.[CrossRef] [PubMed]
[31] Baldé, N.-M., Diallo, I., Baldé, M.-D., Barry, I.-S., Kaba, L., Diallo, M.-M., et al. (2007) Diabetes and Impaired Fasting Glucose in Rural and Urban Populations in Futa Jallon (Guinea): Prevalence and Associated Risk Factors. Diabetes & Metabolism, 33, 114-120.[CrossRef] [PubMed]
[32] Hall, V., Thomsen, R.W., Henriksen, O. and Lohse, N. (2011) Diabetes in Sub Saharan Africa 1999-2011: Epidemiology and Public Health Implications. A Systematic Review. BMC Public Health, 11, Article No. 564.[CrossRef] [PubMed]
[33] Gill, G.V., Mbanya, J.-C., Ramaiya, K.L. and Tesfaye, S. (2008) A Sub-Saharan African Perspective of Diabetes. Diabetologia, 52, 8-16.[CrossRef] [PubMed]

Copyright © 2026 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.